First Turn Management’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-768,662
Closed -$11.5M 36
2026
Q1
$11.5M Buy
768,662
+150,948
+24% +$3.36M 1.28% 31
2025
Q4
$15.4M Buy
+617,714
New +$11M 1.76% 28

Other funds holding OLMA

First Turn Management's OLMA Position: Q2 2026 in Review

First Turn Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 768,662 shares — an estimated $11.5M sold.

First Turn Management first reported a position in OLMA in Q4 2025 and held it in 2 quarters. The position peaked at $15.4M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • First Turn Management reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • First Turn Management sold 768,662 Olema Pharmaceuticals shares in Q2 2026, an estimated $11.5M.
  • First Turn Management first reported a position in Olema Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • First Turn Management's Olema Pharmaceuticals position peaked at $15.4M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.